W. Akpan
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals
Papers in
-
- Epilepsy research and treatment 3
- Attention Deficit Hyperactivity Disorder 1
-
- Pharmacological Effects and Toxicity Studies 3
- Co-authors
- G. Neugebauer (9 shared papers)K. Reiff (4 shared papers)E von Möllendorff (6 shared papers)Peter Neubert (3 shared papers)B. Kaufmann (3 shared papers)Ulrich Martin (2 shared papers)R. Kientsch-Engel (1 shared paper)U. Abshagen (2 shared papers)
- Journals
- Journal of Cardiovascular Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Thrombosis and Haemostasis (1 paper)European Journal of Clinical Pharmacology (1 paper)PubMed (3 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
W. Akpan
9 papers receiving 354 citations
Peers
Comparison fields: 5 of 60
- Pharmacology 81
- Analytical Chemistry 83
- Anesthesiology and Pain Medicine 47
- Cardiology and Cardiovascular Medicine 182
- Internal Medicine 17
Countries citing papers authored by W. Akpan
This map shows the geographic impact of W. Akpan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Akpan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Akpan more than expected).
Fields of papers citing papers by W. Akpan
This network shows the impact of papers produced by W. Akpan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Akpan. The network helps show where W. Akpan may publish in the future.
Co-authors
The 9 scholars most cited alongside W. Akpan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacokinetics and disposition of carvedilol in humans. | 1987 | 113 |
| 2 | 1990 | 98 | |
| 3 | 1987 | 71 | |
| 4 | 1991 | 45 | |
| 5 | 1986 | 27 | |
| 6 | 1991 | 22 | |
| 7 | [Interaction of guar with glibenclamide and bezafibrate]. | 1983 | 5 |
| 8 | Performance of a slow-release formulation of isosorbide-5-mononitrate (ISMO retard). | 1989 | 2 |
| 9 | 1987 | 1 |
About W. Akpan
W. Akpan is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Anesthesiology and Pain Medicine, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 9 papers that have together received 384 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (3 papers), Anesthesia and Sedative Agents (3 papers), Epilepsy research and treatment (3 papers), Protease and Inhibitor Mechanisms (2 papers), Blood properties and coagulation (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers), Attention Deficit Hyperactivity Disorder (1 paper) and Drug Solubulity and Delivery Systems (1 paper). The work is most often cited by research in Pharmacology (81 citations), Analytical Chemistry (83 citations), Anesthesiology and Pain Medicine (47 citations), Cardiology and Cardiovascular Medicine (182 citations) and Internal Medicine (17 citations). W. Akpan has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include G. Neugebauer, K. Reiff, E von Möllendorff, Peter Neubert, B. Kaufmann, Ulrich Martin, R. Kientsch-Engel, U. Abshagen and H Jaeger. Their work appears in journals such as Journal of Cardiovascular Pharmacology, Clinical Pharmacology & Therapeutics, Thrombosis and Haemostasis, European Journal of Clinical Pharmacology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.